Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA’s Fecal Transplant Enforcement Discretion May Jeopardize Rebiotix’s Approval Prospects
Sep 21 2022
•
By
Sarah Karlin-Smith
Rebiotix’s fecal microbiota transplant looks to face uphill fight at FDA advisory committee 22 September • Source: Shutterstock
More from US FDA Performance Tracker
More from Regulatory Trackers